Company Comparison
Millendo Therapeutics vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Millendo Therapeutics | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | South San Francisco, California |
| Founded | — | 2006 |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Millendo Therapeutics
Clinical-stage biopharmaceutical company developing treatments for rare endocrine diseases and hormonal disorders, ceased operations in 2021.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Millendo Therapeutics
Sector Overlap
Both Millendo Therapeutics and 23andMe operate in Biotech.
Browse all Biotech companies →